Synapsoft logo
AI Insights from Disclosures
Searching...
Optipharm.CO.,LTD 153710
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Optipharm.CO.,LTD has performed animal disease diagnosis since it was designated as a livestock disease diagnosis institution in November 2006, and given the technology-driven nature of its service, it secures the technology and experienced human resources that matter most. It was also the first institution to introduce a web-based disease diagnosis system, enabling efficient customer management, and it has built its own diagnosis and testing systems through the development of its own diagnostic products. The company's animal medicine division is the only animal medicine supplier with its own efficacy testing, animal testing, disease diagnosis, and research institutions, and it has an advantage over general animal medicine suppliers in that it can supply animal medicines with proven efficacy based on data secured through efficacy testing, content testing, and antibiotic resistance testing on target animals.
Representative Director Kim Hyeonil
Founded July 27, 2000
Corporation Type KOSDAQ
Industry Classification Manufacture of medical supplies and related other medicaments
Corporate number 13011-0062876
Business number 124-81-75413
Phone Number 043-249-7500
Fax Number 043-249-7501
Company Address 63 Osongsaengmyeong 6-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant